Filing Flows › Crispr Therapeutics AG (CRSP) › Recalls, complaints & regulation
Crispr Therapeutics AG (CRSP): clinical trials
Crispr Therapeutics AG (CRSP) beyond its filings: 8 active clinical trials.
Crispr Therapeutics AG's latest quarter
Crispr Therapeutics AG, Q3 2026: revenue $12.7M (14× year over year), net loss $111M, operating cash flow −$89.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Crispr Therapeutics AG have?
8 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.